Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04265534 |
|---|---|
| Brief Title: | KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC (KEAPSAKE) |
| First Submitted : | February 7, 2020 |
| First Submitted that Met QC Criteria : | February 10, 2020 |
| First Posted : | February 11, 2020 |
| Last Update Submitted that Met QC Criteria : | January 5, 2021 |
| Last Update Posted : | January 7, 2021 |